(NASDAQ: BDSX) Biodesix's forecast annual revenue growth rate of 16.25% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.67%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.24%.
Biodesix's revenue in 2024 is $60,902,000.On average, 2 Wall Street analysts forecast BDSX's revenue for 2024 to be $10,278,540,450, with the lowest BDSX revenue forecast at $10,249,505,025, and the highest BDSX revenue forecast at $10,307,575,875.
In 2025, BDSX is forecast to generate $12,819,140,138 in revenue, with the lowest revenue forecast at $12,790,104,713 and the highest revenue forecast at $12,848,175,563.